□Overview of Foundation
As of March 31, 2014


Kanzawa Medical Research Foundation


19-48, Yoshino, Matsumoto Nagano 399-8710
Competent government Cabinet Office


June 27, 1997
July 1, 2010 (transition to a public interest foundation)


Kunio Kanzawa, Kissei Pharmaceutical Co., Ltd.
History of establishment Established on the basis of private assets offered by Kunio Kanzawa, Chairman of Kissei Pharmaceutical Co., Ltd. and funds provided by Kissei Pharmaceutical Co., Ltd. in commemoration of its 50th anniversary in business.
Basis assets 1,782,106,067JPY As of March 31, 2014
Purpose of establishment Promote development of healthcare and medical science by encouraging studies (hereinafter referred to as subjected studies) from various angles on causes, prevention, diagnoses, therapies, etc. of various diseases occurred in women at reproductive age with focus on perinatal period and elderly/senile women, thereby contributing to enhancement of the people’s health and welfare.
Description of business The following business is conducted to achieve the purpose.
(1) Award excellent research results on the subjected studies
(2) Research grants to subjected studies
(3) Overseas study grants on subjected studies
(4) Organize seminars on subjected studies
Research award/
Subsidiary plan
Kanzawa Medical Award (Research Award):
3 million yen per study For one person
Research grants:
1.5 million yen per study For 10 persons
Overseas study grants:
0.5 million yen per study For 4 persons